期刊文献+

阿昔洛韦二肽修饰物的合成及性质

The Synthesis and Properties of Acyclovir Dipeptide Derivatives
在线阅读 下载PDF
导出
摘要 以阿昔洛韦和琥珀酸酐为原料,100 mL DMF为反应媒介,加入0.7 mL三乙胺,合成琥珀酰阿昔洛韦[9-(2-丁二酸单酰乙氧基甲基)鸟嘌呤](SACV),然后利用Fmoc固相合成法合成三个新的阿昔洛韦二肽衍生物(SACV-Glu-Lys,SACV-Glu-Ala,SACV-Val-Lys).利用1H NMR和ESI-MS分析手段对其结构进行表征.并考察了二肽修饰过的阿昔洛韦,水溶性,油脂分配系数.结果表明含有较长的侧链酸性氨基酸与碱性氨基酸形成的二肽所修饰阿昔洛韦,既可以较大的提高阿昔洛韦(ACV)的水溶性又能够得到油水分配系数较高的ACV二肽衍生物. Succinyl acyclovir (SACV) was prepared by acyclovir coupled with succinic anhydride as materials and 100 mL DMF as the reaction medium, adding 0.7 mL of triethylamine. Then three new aeyclovir dipeptide derivatives SACV-GIu-Lys, SACV-GIu-Ala and SACV-Val-Lys were synthesized by Fmoc solid synthesis method. The structures of SACV and three new acyclovir dipeptide derivatives were characterized by 1H NMR and ESI-MS, water-solubility and oil partition coefficient of the dipeptide modified aeyelovir were also investigated. The results showed that dipeptide modified aeyclovir was achieved with the use of acidic amino acid and alkaline amino acid containing longer side chains, its water-solubility was greatly improved and oil-water partition coefficient of the ACV dipeptide derivatives was also increased.
出处 《河南科学》 2014年第5期711-715,共5页 Henan Science
基金 国家自然科学基金(21172054) 河南省创新型科技人才队伍建设工程(104200510022)
关键词 阿昔洛韦 琥珀酰阿昔洛韦 固相合成法 二肽 acyclovir; succinylacyclovir; solid phasesynthesis; dipeptide
  • 相关文献

参考文献12

  • 1Cohen J. A powerful and perplexing new HIV prevention tool[J].Science, 2010, 330: 1298-1299.
  • 2冷玲颖,蔡志强,孙铁民.核苷类抗病毒前药的研究进展[J].中国药物化学杂志,2008,18(4):310-316. 被引量:20
  • 3钟敬波.抗乙肝病毒核苷类药物的研究进展[J].中国热带医学,2007,7(11):2114-2115. 被引量:12
  • 4Dhaneshwar S, Tewari K, Joshi S, et al. Diglyceride prodrug strategy for enhancing the bioavailability of norfloxacin [J]. Chemistry and Physics of Lipids, 2011,164: 307-313.
  • 5Bonina F, Fuglla C, Rimoli M C. Derivatives of dopamicne and L-dopa as anti-Parkinson prodrug: synthesis, pharmacological activity and in vitro stability studies[J]. J Drug Target, 2003, 11 : 25-36.
  • 6Cledir R. Santosa, Rita capela structure-activity relationships for dipeptide prodrugs of acyclovir : Implications for prodrug design[J]. European Journal of Medicinal Chemistry, 2009(44) : 2339-2346.
  • 7Hong Lu, Curtis Klaassen. Tissue distribution and thyroid hormone regulation of Pept 1 and Pept2 mRNA in rodents[J]. Peptides, 2006(27) : 850-857.
  • 8Marx V. Watching peptide drugs grow up[J]. Chem Eng News, 2005,83: 17-24.
  • 9Rajeev K, Meenakshi R, Prabodh C S, et al. Therapeutic importance of peptidomimetics in medicinal chemistry [J]. J Chem Pharm Res, 2011,3: 173-186.
  • 10Tao Y Y, Lu Y F, Sun Y J, et al. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability [J]. International Journal of Pharmaceutics, 2009, 378: 30-36.

二级参考文献69

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部